Health Canada drug identification number

DIN 02495244 — VASCEPA 1 G

VASCEPA is a capsule of Icosapent ethyl marketed by HLS THERAPEUTICS INC. The full Icosapent ethyl monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02495244
Brand name
VASCEPA
Active ingredient
Icosapent ethyl
Strength
1 G
Dosage form
CAPSULE
Route
ORAL
Manufacturer
HLS THERAPEUTICS INC
Health Canada status
MARKETED
Drug class
Lipid-regulating agent (omega-3 fatty acid derivative)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.